• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAINSTAY MEDICAL LIMITED REACTIV8; REACTIV8 SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAINSTAY MEDICAL LIMITED REACTIV8; REACTIV8 SYSTEM Back to Search Results
Model Number 5100
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Urticaria (2278)
Event Date 06/08/2023
Event Type  Injury  
Manufacturer Narrative
B2- other: skin rash.Other devices: model number: 8145.Description: stimulation implantable leads.Serial number: (b)(6).Manufacturing date: 03/19/2022.Mml ref # (b)(4).
 
Event Description
It was reported that the patient gets skin rash all over his body when the stimulation is activated.The patient requested an explant of the device.The device was explanted successfully with no report of patient harm or injury.The patient reported that the skin rash occurred immediately upon activating the reactiv8 system.There was no medical intervention performed for the rash.According to the patient, the skin rash is exclusively in the back, lasts several days, and occurs every stimulation.The patient confirmed stimulation was not painful.The patient was activated 14 days after the implantation of the device ((b)(6) 2023).The mainstay medical therapy manager and the physician did not notice a rash, and the patient did not complaint of a rash or other issues at the time of activation.A review of the device log, the patient only performed one session per day on average, predominantly delivered in the evening.The device operated as expected.It was not confirmed that the patient experienced a skin rash during stimulation because the patient stopped using the device on (b)(6) 2023.All impedances were stable throughout.After explant, the device was received for evaluation.The implantable pulse generator and the stimulation leads performed normally during testing.A review of the device manufacturing and sterilization revealed no non-conformances that would have contributed to the skin rash reported by the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REACTIV8
Type of Device
REACTIV8 SYSTEM
Manufacturer (Section D)
MAINSTAY MEDICAL LIMITED
clonmel house, forster way
swords, county dublin K67F2
EI  K67F2
Manufacturer Contact
liza dominguez
6601 shingle creek parkway
suite 200
brooklyn center, MN 55430
6192063331
MDR Report Key17287228
MDR Text Key318778990
Report Number3013017877-2023-00025
Device Sequence Number1
Product Code QLK
UDI-Device Identifier05391527770015
UDI-Public(01)05391527770015
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P190021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 07/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/10/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number5100
Device Catalogue Number5100
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/14/2023
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/22/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/18/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-